Patients with hereditary hemochromatosis often have iron overload, myocardial hypertrophy, and decreased left ventricular ejection fraction [104]
excellent work thanks for your help Jose Saucedo Ms
These observations led to an interesting development bifurcation : Melanotan I (Afamelanotide) continued as a skin peptide and in 2014 received approval as Scenesse for erythropoietic protoporphyria (a rare genetic disease with severe photosensitivity) Melanotan II was abandoned as a cutaneous drug PT-141 / Bremelanotide , a fragment of Melanotan II targeted at MC4R, was developed as a sexual stimulant and in 2019 approved as Vyleesi for hypoactive sexual desire disorder in women (HSDD) Second life in research and the cosmetic underground Melanotan II never reached commercial approval as a drug, but in the research community and cosmetic underground it became well known
Wear sunscreen daily and avoid harsh skin products for the first week after treatment
Any symptoms you have noticed since combining them, including changes in nausea, blood sugar readings, or fatigue
[8] It also improves liver conditions and potentially preventing fibrosis progression
